Arkolith/Insider Trading/TXMD/Form 4

Walker Marlan D

Chief Executive OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Feb 20, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2025Option exercise(M)770—$069K
Feb 18, 2025Option exercise(M)2K—$071K
Feb 18, 2025Option exercise(M)2K—$068K
Feb 18, 2025Option exercise(M)3K—$066K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2025Option exercise(M)770—$00
Feb 18, 2025Option exercise(M)2K—$00
Feb 18, 2025Option exercise(M)3K—$00
Feb 18, 2025Option exercise(M)2K—$02K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-000737) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML